Statement of Organization, Functions, and Delegations of Authority, 35676-35679 [2019-15691]
Download as PDF
35676
Federal Register / Vol. 84, No. 142 / Wednesday, July 24, 2019 / Notices
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications will also be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than August 16,
2019.
A. Federal Reserve Bank of Kansas
City (Dennis Denney, Assistant Vice
President) 1 Memorial Drive, Kansas
City, Missouri 64198–0001:
1. Fidelity Financial Bancorporation,
Wichita, Kansas; to become a bank
holding company upon the conversion
of its subsidiary Fidelity Bank, Wichita,
Kansas, to a commercial bank.
Board of Governors of the Federal Reserve
System, July 18, 2019.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2019–15646 Filed 7–23–19; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
khammond on DSKBBV9HB2PROD with NOTICES
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 84 FR 34177–34184,
dated July 17, 2019) is amended to
reflect the reorganization of the National
Center on Birth Defects and
Developmental Disabilities, Deputy
Director for Non-Infectious Diseases,
Centers for Disease Control and
Prevention. This reorganization will
VerDate Sep<11>2014
16:53 Jul 23, 2019
Jkt 247001
align budget lines and similar
programmatic areas under the same
divisions and branches.
I. Under Part C, Section C–B,
Organization and Functions, the
following organizational unit is deleted
in its entirety:
• Developmental Disabilities Branch
(CUBBD).
II. Under Part C, Section C–B,
Organization and Functions, make the
following changes:
• Update the functional state for the
Office of the Director (CUB1).
• Update the functional statements
for the Resource Management Office
(CUB12).
• Retitle the Division of Congenital
and Developmental Disorders (CUBB) to
the Division of Birth Defects and Infant
Disorders (CUBB) and update its
functional statement.
• Update the functional statement for
the Office of the Director (CUBB1).
• Retitle the Birth Defects Branch
(CUBBB) to the Birth Defects Monitoring
and Research Branch (CUBBB) and
update its functional statement.
• Retitle the Prevention Research and
Translation Branch (CUBBC) to the
Infant Outcomes Monitoring, Research
and Prevention Branch (CUBBC) and
update its functional statement.
• Update the functional statement for
the Division of Human Development
and Disability (CUBC).
• Update the functional statement for
the Child Development and Disability
Branch (CUBCB).
• Retitle the Disability and Health
Branch (CUBCC) to the Disability and
Health Promotion Branch.
III. Under Part C, Section C–B,
Organization and Functions, insert the
following:
• Office of the Director (CUB1). (1)
Directs, manages, and coordinates the
activities of the NCBDDD; (2) develops
goals and objectives; provides
leadership, policy formulation,
scientific oversight, and guidance in
program planning and development; (3)
coordinates NCBDDD program activities
with other CDC components, federal
agencies, state and local health agencies,
business and industry, voluntary
organizations, and community-based
organizations; (4) coordinates technical
assistance to states, other nations and
international organizations; (5)
coordinates with medical, scientific,
and other professional organizations
interested in birth defects prevention,
pediatric genetics, developmental
disabilities prevention, and disabilities
and health, and prevention of
complications of hereditary blood
disorders; (6) advises the CDC Director
on policy matters concerning NCBDDD
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
activities; (7) oversees and coordinates
the translation of scientific findings for
health care providers, public health
professionals, and the public on these
conditions; (8) ensures NCBDDD
produces the highest quality, most
relevant and useful science possible; (9)
oversees scientific clearance of
NCBDDD documents and digital
materials and coordinates crossclearance of materials; (10) provides
information and guidance to the staff
regarding scientific issues and provides
scientific leadership for the center; (11)
provides ongoing communication
leadership and support to NCBDDD’s
Office of the Director and divisions in
furthering the Centers’ mission; leads
strategic planning for communications
and branding of NCBDDD programs and
projects; (12) leads and oversees news
media strategy and evaluation; (13)
facilitates clearance and cross-clearance
of NCBDDD print and digital materials,
ensuring adherence to CDC and
Department of Health and Human
Services (DHHS) information and
publication policies; (14) reviews,
prepares and coordinates policy and
briefing documents; (15) conducts
monitoring and analysis of policy issues
potentially affecting NCBDDD and its
constituents; and (16) provides
information for the development of the
NCBDDD’s annual budget submission.
• Resource Management Office
(CUB12). (1) Plans, coordinates, and
provides administrative and
management advice and guidance for
NCBDDD; (2) provides and coordinates
center-wide administrative,
management, and support services in
the areas of fiscal management,
personnel, travel, procurement, facility
management, and other administrative
services; (3) prepares annual budget
plans and budget justifications; (4)
develops annual budget plans and
budget justifications; (5) monitors
NCBDDD spend plans to ensure ceiling
levels are at or below specified levels;
(6) coordinates NCBDDD requirements
relating to contracts, grants, cooperative
agreements, and reimbursable
agreements; (7) develops and
implements administrative policies,
procedures, and operations, as
appropriate, for NCBDDD, and prepares
special reports and studies, as required,
in the administrative management areas;
and (8) maintains liaison with related
staff offices and other officials of CDC
on behalf of NCBDDD.
• Division of Birth Defects and Infant
Disorders (CUBB). The Division of Birth
Defects and Infant Disorders works to
identify causes of birth defects and
infant disorders through surveillance
and public health research, and
E:\FR\FM\24JYN1.SGM
24JYN1
khammond on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 84, No. 142 / Wednesday, July 24, 2019 / Notices
conducts prevention research and
programs to improve health across the
lifespan. This division: (1) Conducts
epidemiological research to determine
the causes and prevention of birth
defects and developmental disabilities;
(2) maintains and expands support for
state-based surveillance; (3) evaluates
the effectiveness of efforts to prevent
birth defects and developmental
disabilities; (4) conducts and
disseminates findings of epidemiologic
research, investigations,
demonstrations, and programs directed
toward the prevention of selected
adverse reproductive outcomes that are
environmentally related; (5) provides
assistance to state and local health
departments on community exposures
to terotogenic, mutagenic, embryotoxic,
other environmental agents, and genetic
influences adversely interfering with
normal growth and development; (6)
conducts research and epidemiologic
studies to develop intervention
programs to reduce alcohol and other
substance exposed pregnancies and
monitors infant outcomes to identify
and better understand the needs and
develop interventions to improve the
trajectory for substance exposed infants;
(7) works closely with international
organizations and entities in developing
strategies and programs for reducing the
number of birth defects and
developmental disabilities; (8) develops
and evaluates prevention strategies and
provides training, technical
consultation, and assistance to States
and localities in developing their
capacity for planning, establishing, and
maintaining surveillance and
prevention programs; (9) plans,
develops, establishes, and maintains
systems of surveillance including
registries for monitoring, evaluating and
disseminating information; (11) assists
in increasing the capacity of states,
localities, international organizations,
and non-governmental organizations to
prevent and control birth defects and
developmental disabilities through
training, technology transfer, grants,
cooperative agreements, contracts, and
other means; (12) provides information
and education to the public; (13)
provides services, consultation,
technical assistance, and information to
States, localities, other Federal agencies,
international organizations, and other
public and private organizations; (14)
provides training in the epidemiology to
professionals throughout the U.S. and
abroad; and (15) collaborates and
coordinates activities with other CIOs
and HHS agencies.
• Office of the Director (CUBB1). (1)
Manages, directs, and coordinates the
VerDate Sep<11>2014
16:53 Jul 23, 2019
Jkt 247001
research agenda and activities of the
division; (2) provides leadership and
guidance on strategic planning, policy,
program and project priority planning
and setting, program management, and
operations; (3) establishes division
goals, objectives, and priorities; (4)
monitors progress in implementation of
projects and achievement of objectives;
(5) plans, allocates, and monitors
resources; (6) provides management,
administrative, and support services,
and coordinates with appropriate
NCBDDD offices on program and
administrative matters; (7) provides
liaison with other CDC organizations,
other governmental agencies,
international organizations, and other
outside groups; (8) provides support for
internal scientific advisory groups; (9)
provides scientific leadership and
guidance to the division to assure
highest scientific quality and
professional standards; and (10)
researches, identifies and executes
prevention messaging and interventions
to reduce adverse birth outcomes.
• Birth Defects Monitoring and
Research Branch (CUBBB). (1) Designs
and conducts epidemiologic and genetic
research to identify causes and risk
factors of birth defects; (2) conducts and
evaluates interventions to improve
infant and child health by preventing or
reducing the adverse consequences of
birth defects; (3) designs and conducts
surveillance of selected birth defects to
identify rates, trends, and patterns of
occurrence, and to evaluate the
effectiveness of prevention programs; (4)
disseminates findings of studies to the
scientific and public health
communities, and to the general public;
(5) provides technical assistance to state
and local agencies on surveillance of
birth defects, epidemiologic research,
prevention program design and
evaluation, and prevention effectiveness
research; (6) funds and coordinates
grant and cooperative agreement
programs and other extramural activities
to improve the knowledge base for the
prevention of birth defects through
surveillance, epidemiologic research,
and applies research of preventive
interventions; (7) coordinates activities
with other CDC functional units, HHS,
other federal agencies, and appropriate
private organizations regarding research
and prevention programs for birth
defects; (8) works with international
organizations in developing strategies
for the prevention of birth defects; and
(9) disseminates findings of research
through direct contact with health
authorities, publication and distribution
of special reports, publication in
scientific and technical journals,
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
35677
conference presentations, and other
appropriate means.
• Infant Outcomes Monitoring,
Research and Prevention Branch
(CUBBC). (1) Designs and conducts
surveillance of preventable birth defects
due to substance exposure during
pregnancy, and emerging threats to
mothers and babies; (2) identifies and
monitors major preconception, prenatal
and perinatal risks, and protective
factors for fetal alcohol spectrum
disorders (FASD) and other prenatal
alcohol and substance-attributable
conditions and other threats to mothers
and their babies; (3) identifies rates,
trends, and patterns of occurrence; (4)
modifies the impact of prenatal
exposures leading to adverse physical
and developmental impairments in
infants, children, and adults including
integrating successful prevention
programs into social and medical
environments, and evaluating
innovative, effective, and strategic
health promotion programs; (5)
develops, implements, evaluates, and
disseminates education and
communication interventions that lead
to the prevention of birth defects and
developmental disabilities; (6)
disseminates findings of epidemiologic
studies to the scientific and public
health communities, and to the general
public; (7) conducts prevention
effectiveness research to evaluate
interventions strategies for the
prevention of birth defects and
developmental disabilities; (8) provides
technical assistance to state and local
agencies on surveillance, epidemiologic
research, prevention program design
and evaluation, and prevention
effectiveness research; (9) funds and
coordinates grant and cooperative
agreement programs and other
extramural activities to improve the
knowledge base for the prevention of
birth defects and developmental
disabilities through surveillance,
epidemiologic research, and applies
research of preventive interventions;
(10) coordinates activities with other
CDC functional units, HHS, other
federal agencies and appropriate private
organizations regarding research and
prevention programs for birth defects
and developmental disabilities; (11)
works with international organizations
in developing strategies for the
prevention of birth defects and
developmental disabilities; and (12)
disseminates finding of research
through direct contact with health
authorities, publication and distribution
of special reports, publication in
scientific and technical journals,
E:\FR\FM\24JYN1.SGM
24JYN1
khammond on DSKBBV9HB2PROD with NOTICES
35678
Federal Register / Vol. 84, No. 142 / Wednesday, July 24, 2019 / Notices
conference presentations, and other
appropriate means.
• Division of Human Development
and Disability (CUBC). The Division of
Human Development and Disability
works to help children and adults living
with Autism, Attention Deficit
Hyperactivity Disorder (ADHD),
Tourette Syndrome (TS) and other
developmental disabilities live to the
fullest through better understanding
developmental disabilities from early
detection into adulthood. The division
improves the health for children and
adults with disabilities, in particular,
people with mobility limitations,
intellectual disability and hearing loss
by informing disability health policy
and practice, and dissemination of
disability health inclusion resources.
This division: (1) Designs and conducts
surveillance of developmental
disabilities to identify rates, trends, and
patterns of occurrence, and to evaluate
the effectiveness of prevention
programs; (2) conducts epidemiologic
studies of developmental disabilities to
identify causes and risk factors for these
conditions; (3) disseminates findings of
epidemiologic studies to the scientific
and public health communities and to
the general public; (4) conducts applied
research on public health aspects of
normal and abnormal child
development (e.g., early childhood,
behavior problems in children); (5)
conducts research on interventions to
prevent adverse child developmental
outcomes; (6) develops and
disseminates information on public
health aspects of normal and abnormal
child development; (9) conducts,
analyzes, and disseminates surveillance
data to identify the distribution of
disabilities in state populations; health
conditions that occur with greater
frequency among people with
disabilities; and risk and protective
behaviors compared to people without
disabilities; (10) assists states and
localities in developing their capacity
for serving individuals with
developmental and other disabilities
(e.g., developing prevention strategies,
providing training and technical
consultation) to prevent secondary
conditions; (11) collaborates with
universities, federal, national, and state
organizations to identify and address
knowledge and research gaps in
developmental health and disability;
(12) collaborates with universities and
other organizations to investigate
environmental, social, and technological
supports to promote inclusion; (13)
develops programs that seek to identify
health risks, protective factors and
measure the effectiveness of health
VerDate Sep<11>2014
16:53 Jul 23, 2019
Jkt 247001
promotion activities for prevention of
conditions related to disability; and (14)
oversees and manages grants,
cooperative agreements, contracts, and
other funding instruments related to
division programs.
• Child Development and Disability
Branch (CUBCB). (1) Promotes optimal
child development and early
identification of children with
developmental delays through
assessing, developing, implementing,
disseminating and supporting evidencebased practices, tools, and resources; (2)
helps children and adults with autism,
ADHD, TS and other developmental
disabilities live to the fullest by
understanding preventable risk factors,
opportunities for early intervention, and
the effects of these disorders throughout
the lifespan; (3) designs and conducts
surveillance of developmental
disabilities to identify rates, trends, and
patterns of occurrence, and to evaluate
the effectiveness of prevention
programs; (4) conducts epidemiologic
studies of developmental disabilities to
identify causes and risk factors for these
conditions; (5) disseminates findings of
epidemiologic studies to the scientific
and public health communities and to
the general public; (6) conducts
prevention effectiveness research to
evaluate interventions strategies for the
prevention of developmental
disabilities; (7) conducts epidemiologic
studies to identify and describe specific
conditions and long-term outcomes of
developmental disabilities; (8) provides
technical assistance to state and local
agencies on surveillance of
developmental disabilities,
epidemiologic research, prevention
program design and evaluation, and
prevention effectiveness research; (9)
provides scientific leadership and
technical assistance in the development,
application, improvement and
evaluation of public health activities,
systems, and interventions supporting
optimal child development, including
those with or at risk for disabilities; (10)
coordinates and collaborates on
recommendations for policy
development at the federal and state
levels and with the private sector to
promote social participation and
optimal child development, including
those with or at risk for disabilities; (11)
conducts research to expand the
knowledge base related to optimal early
development and health of children
with or at risk of disabilities, and
investigates costs and effectiveness of
intervention programs and systems; (12)
funds and coordinates grant and
cooperative agreement programs and
other extramural activities to improve
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
the knowledge base for the prevention
of developmental disabilities through
surveillance, epidemiologic research,
and applies research of preventive
interventions; (13) coordinates activities
with other CDC functional units, HHS,
other federal agencies and appropriate
private organizations regarding research
and prevention programs for
developmental disabilities; (14)
collaborates with international
organizations in developing strategies
for the prevention of developmental
disabilities; (15) disseminates findings
of research through direct contact with
health authorities, publication and
distribution of special reports,
publication in scientific and technical
journals, conference presentations, and
other appropriate means; and (16)
provides training in the epidemiology of
developmental disabilities to
professionals throughout the United
States and abroad.
• Disability and Health Promotion
Branch (CUBCC). (1) Assists states and
localities with the development,
monitoring and evaluation of early
hearing detection and intervention
(EHDI) tracking and surveillance
systems; (2) conducts research on
etiology of hearing loss and associated
disabilities, cost and effectiveness and
long-term benefits of early identification
and intervention (3) supports statebased disability and health promotion
programs, national, and state
organizations that promote and inform
disability policy and practice, including
assessing, developing, implementing,
and disseminating disability inclusion
models, tools, and resources; (4)
collaborates with and provides technical
assistance, consultation, and training to
local, state, federal, and international
agencies, universities and governmental
and non-governmental organizations on
disability and health related issues; (5)
collaborates with local, state, federal,
and international agencies, and
appropriate governmental and nongovernmental organizations to develop,
review, and implement policies that
advance the health of people with
disabilities across the lifespan; (6)
provides scientific leadership in the
development, application, extension,
and improvement of health surveillance
and tracking systems related to
disability and health; (7) conducts and
supports both qualitative and
quantitative research to expand the
knowledge base related to disability and
health across the lifespan; (8)
disseminates information from
surveillance and health services
research, epidemiological research,
health promotion and disease
E:\FR\FM\24JYN1.SGM
24JYN1
35679
Federal Register / Vol. 84, No. 142 / Wednesday, July 24, 2019 / Notices
prevention strategies, and policies
related to disability and health; (9)
establishes collaborative partnerships
with public and private organizations of
national and international stature to
promote the health of people with
disabilities; (10) collaborates with
funded non-governmental agencies to
disseminate best practices, identify
areas of need, facilitate development
and distribution of educational
materials, and provide informational
resources to states and affected
populations and their caregivers; and
(11) provides leadership in health
promotion and disease prevention
across the lifespan for individuals with
disabilities.
IV. Delegations of Authority: All
delegations and redelegations of
authority made to officials and
employees of affected organizational
components will continue in them or
their successors pending further
redelegation, provided they are
consistent with this reorganization.
(Authority: 44 U.S.C. 3101)
Alex M. Azar II,
Secretary.
[FR Doc. 2019–15691 Filed 7–23–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review; Assets
For Independence (AFI) Performance
Progress Report (PPR) (OMB #0970–
0483)
Office of Community Services;
Administration for Children and
Families; HHS.
AGENCY:
ACTION:
Request for public comment.
The Office of Community
Services (OCS), Administration for
Children and Families (ACF) is
requesting approval of a three-year
extension of the Assets for
Independence (AFI) Performance
Progress Report (PPR) Long Form and
AFI PPR Short Form (OMB #0970–0483,
expiration 8/31/2019). There are no
changes requested to the forms.
DATES: Comments due within 30 days of
publication. OMB is required to make a
decision concerning the collection of
information between 30 and 60 days
after publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication.
SUMMARY:
Written comments and
recommendations for the proposed
information collection should be sent
directly to the following: Office of
Management and Budget, Paperwork
Reduction Project, Email: OIRA_
SUBMISSION@OMB.EOP.GOV, Attn:
Desk Officer for the Administration for
Children and Families.
Copies of the proposed collection may
be obtained by emailing infocollection@
acf.hhs.gov. Alternatively, copies can
also be obtained by writing to the
Administration for Children and
Families, Office of Planning, Research,
and Evaluation, 330 C Street SW,
Washington, DC 20201, Attn: OPRE
Reports Clearance Officer. All requests,
emailed or written, should be identified
by the title of the information collection.
SUPPLEMENTARY INFORMATION:
Description: The Assets for
Independence (AFI) Act (Title IV of the
Community Opportunities,
Accountability, and Training and
ADDRESSES:
Educational Services Act of 1998, Public
Law 105–285, [42 U.S.C. 604]) requires
that organizations operating AFI
projects submit semi-annual progress
reports.
OCS will continue collecting key
information about projects funded
through the AFI program. The AFI PPR
will continue to collect data on project
activities and attributes, where OCS will
use the data to critically review the
overall design and effectiveness of the
program. OCS will use the data
collected in the AFI PPR to prepare the
annual AFI Report to Congress, to
evaluate and monitor the performance
of the AFI Program overall and of
individual projects, and to inform and
support technical assistance efforts. The
AFI PPR will continue to fulfill AFI Act
reporting requirements and program
purposes.
AFI program grantees are required to
submit Standard Form Performance
Progress Reports (SF–PPR)
semiannually: One time per year using
an abbreviated short form and one time
using a long form. Both data collection
instruments are available for review
online at:
https://www.acf.hhs.gov/ocs/resource/
afi-ppr-long-form,
https://www.acf.hhs.gov/ocs/resource/
afi-ppr-short-form.
Note: This request does not affect financial
reporting requirements for AFI grantees. The
SF–425 will still be required semiannually
throughout the grant project period with a
final report due 90 days after the grant
project period ends.
Respondents: Assets for
Independence (AFI) program grantees.
ANNUAL BURDEN ESTIMATES
Total
number of
respondents
Instrument
khammond on DSKBBV9HB2PROD with NOTICES
AFI PPR Short Form .......................................................................................
AFI PPR Long Form ........................................................................................
145
145
Estimated Total Annual Burden
Hours: 623.5.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Authority: Pub. L. 105–285, [42 U.S.C.
604].
Administration for Community Living
Mary B. Jones,
ACF/OPRE Certifying Officer.
Intent To Award a Single-Source
Supplement for the Senior Medicare
Patrol National Resource Center
[FR Doc. 2019–15731 Filed 7–23–19; 8:45 am]
BILLING CODE 4184–24–P
VerDate Sep<11>2014
16:53 Jul 23, 2019
ACTION:
Jkt 247001
PO 00000
Notice.
Frm 00092
Fmt 4703
Sfmt 4703
Annual
number of
responses per
respondent
1
1
Average
burden
hours per
response
0.5
3.8
Annual
burden
hours
72.5
551
The Administration for Community
Living (ACL) announces the intent to
award a single-source supplement to the
current cooperative agreement held by
the Northeast Iowa Area Agency on
Aging, Inc. (NEI3A) for the Senior
Medicare Patrol National Resource
Center (SMPRC). The purpose of the
SMPRC is to provide professional
expertise, training, and technical
E:\FR\FM\24JYN1.SGM
24JYN1
Agencies
[Federal Register Volume 84, Number 142 (Wednesday, July 24, 2019)]
[Notices]
[Pages 35676-35679]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-15691]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 84 FR 34177-34184, dated July 17, 2019) is
amended to reflect the reorganization of the National Center on Birth
Defects and Developmental Disabilities, Deputy Director for Non-
Infectious Diseases, Centers for Disease Control and Prevention. This
reorganization will align budget lines and similar programmatic areas
under the same divisions and branches.
I. Under Part C, Section C-B, Organization and Functions, the
following organizational unit is deleted in its entirety:
Developmental Disabilities Branch (CUBBD).
II. Under Part C, Section C-B, Organization and Functions, make the
following changes:
Update the functional state for the Office of the Director
(CUB1).
Update the functional statements for the Resource
Management Office (CUB12).
Retitle the Division of Congenital and Developmental
Disorders (CUBB) to the Division of Birth Defects and Infant Disorders
(CUBB) and update its functional statement.
Update the functional statement for the Office of the
Director (CUBB1).
Retitle the Birth Defects Branch (CUBBB) to the Birth
Defects Monitoring and Research Branch (CUBBB) and update its
functional statement.
Retitle the Prevention Research and Translation Branch
(CUBBC) to the Infant Outcomes Monitoring, Research and Prevention
Branch (CUBBC) and update its functional statement.
Update the functional statement for the Division of Human
Development and Disability (CUBC).
Update the functional statement for the Child Development
and Disability Branch (CUBCB).
Retitle the Disability and Health Branch (CUBCC) to the
Disability and Health Promotion Branch.
III. Under Part C, Section C-B, Organization and Functions, insert
the following:
Office of the Director (CUB1). (1) Directs, manages, and
coordinates the activities of the NCBDDD; (2) develops goals and
objectives; provides leadership, policy formulation, scientific
oversight, and guidance in program planning and development; (3)
coordinates NCBDDD program activities with other CDC components,
federal agencies, state and local health agencies, business and
industry, voluntary organizations, and community-based organizations;
(4) coordinates technical assistance to states, other nations and
international organizations; (5) coordinates with medical, scientific,
and other professional organizations interested in birth defects
prevention, pediatric genetics, developmental disabilities prevention,
and disabilities and health, and prevention of complications of
hereditary blood disorders; (6) advises the CDC Director on policy
matters concerning NCBDDD activities; (7) oversees and coordinates the
translation of scientific findings for health care providers, public
health professionals, and the public on these conditions; (8) ensures
NCBDDD produces the highest quality, most relevant and useful science
possible; (9) oversees scientific clearance of NCBDDD documents and
digital materials and coordinates cross-clearance of materials; (10)
provides information and guidance to the staff regarding scientific
issues and provides scientific leadership for the center; (11) provides
ongoing communication leadership and support to NCBDDD's Office of the
Director and divisions in furthering the Centers' mission; leads
strategic planning for communications and branding of NCBDDD programs
and projects; (12) leads and oversees news media strategy and
evaluation; (13) facilitates clearance and cross-clearance of NCBDDD
print and digital materials, ensuring adherence to CDC and Department
of Health and Human Services (DHHS) information and publication
policies; (14) reviews, prepares and coordinates policy and briefing
documents; (15) conducts monitoring and analysis of policy issues
potentially affecting NCBDDD and its constituents; and (16) provides
information for the development of the NCBDDD's annual budget
submission.
Resource Management Office (CUB12). (1) Plans,
coordinates, and provides administrative and management advice and
guidance for NCBDDD; (2) provides and coordinates center-wide
administrative, management, and support services in the areas of fiscal
management, personnel, travel, procurement, facility management, and
other administrative services; (3) prepares annual budget plans and
budget justifications; (4) develops annual budget plans and budget
justifications; (5) monitors NCBDDD spend plans to ensure ceiling
levels are at or below specified levels; (6) coordinates NCBDDD
requirements relating to contracts, grants, cooperative agreements, and
reimbursable agreements; (7) develops and implements administrative
policies, procedures, and operations, as appropriate, for NCBDDD, and
prepares special reports and studies, as required, in the
administrative management areas; and (8) maintains liaison with related
staff offices and other officials of CDC on behalf of NCBDDD.
Division of Birth Defects and Infant Disorders (CUBB). The
Division of Birth Defects and Infant Disorders works to identify causes
of birth defects and infant disorders through surveillance and public
health research, and
[[Page 35677]]
conducts prevention research and programs to improve health across the
lifespan. This division: (1) Conducts epidemiological research to
determine the causes and prevention of birth defects and developmental
disabilities; (2) maintains and expands support for state-based
surveillance; (3) evaluates the effectiveness of efforts to prevent
birth defects and developmental disabilities; (4) conducts and
disseminates findings of epidemiologic research, investigations,
demonstrations, and programs directed toward the prevention of selected
adverse reproductive outcomes that are environmentally related; (5)
provides assistance to state and local health departments on community
exposures to terotogenic, mutagenic, embryotoxic, other environmental
agents, and genetic influences adversely interfering with normal growth
and development; (6) conducts research and epidemiologic studies to
develop intervention programs to reduce alcohol and other substance
exposed pregnancies and monitors infant outcomes to identify and better
understand the needs and develop interventions to improve the
trajectory for substance exposed infants; (7) works closely with
international organizations and entities in developing strategies and
programs for reducing the number of birth defects and developmental
disabilities; (8) develops and evaluates prevention strategies and
provides training, technical consultation, and assistance to States and
localities in developing their capacity for planning, establishing, and
maintaining surveillance and prevention programs; (9) plans, develops,
establishes, and maintains systems of surveillance including registries
for monitoring, evaluating and disseminating information; (11) assists
in increasing the capacity of states, localities, international
organizations, and non-governmental organizations to prevent and
control birth defects and developmental disabilities through training,
technology transfer, grants, cooperative agreements, contracts, and
other means; (12) provides information and education to the public;
(13) provides services, consultation, technical assistance, and
information to States, localities, other Federal agencies,
international organizations, and other public and private
organizations; (14) provides training in the epidemiology to
professionals throughout the U.S. and abroad; and (15) collaborates and
coordinates activities with other CIOs and HHS agencies.
Office of the Director (CUBB1). (1) Manages, directs, and
coordinates the research agenda and activities of the division; (2)
provides leadership and guidance on strategic planning, policy, program
and project priority planning and setting, program management, and
operations; (3) establishes division goals, objectives, and priorities;
(4) monitors progress in implementation of projects and achievement of
objectives; (5) plans, allocates, and monitors resources; (6) provides
management, administrative, and support services, and coordinates with
appropriate NCBDDD offices on program and administrative matters; (7)
provides liaison with other CDC organizations, other governmental
agencies, international organizations, and other outside groups; (8)
provides support for internal scientific advisory groups; (9) provides
scientific leadership and guidance to the division to assure highest
scientific quality and professional standards; and (10) researches,
identifies and executes prevention messaging and interventions to
reduce adverse birth outcomes.
Birth Defects Monitoring and Research Branch (CUBBB). (1)
Designs and conducts epidemiologic and genetic research to identify
causes and risk factors of birth defects; (2) conducts and evaluates
interventions to improve infant and child health by preventing or
reducing the adverse consequences of birth defects; (3) designs and
conducts surveillance of selected birth defects to identify rates,
trends, and patterns of occurrence, and to evaluate the effectiveness
of prevention programs; (4) disseminates findings of studies to the
scientific and public health communities, and to the general public;
(5) provides technical assistance to state and local agencies on
surveillance of birth defects, epidemiologic research, prevention
program design and evaluation, and prevention effectiveness research;
(6) funds and coordinates grant and cooperative agreement programs and
other extramural activities to improve the knowledge base for the
prevention of birth defects through surveillance, epidemiologic
research, and applies research of preventive interventions; (7)
coordinates activities with other CDC functional units, HHS, other
federal agencies, and appropriate private organizations regarding
research and prevention programs for birth defects; (8) works with
international organizations in developing strategies for the prevention
of birth defects; and (9) disseminates findings of research through
direct contact with health authorities, publication and distribution of
special reports, publication in scientific and technical journals,
conference presentations, and other appropriate means.
Infant Outcomes Monitoring, Research and Prevention Branch
(CUBBC). (1) Designs and conducts surveillance of preventable birth
defects due to substance exposure during pregnancy, and emerging
threats to mothers and babies; (2) identifies and monitors major
preconception, prenatal and perinatal risks, and protective factors for
fetal alcohol spectrum disorders (FASD) and other prenatal alcohol and
substance-attributable conditions and other threats to mothers and
their babies; (3) identifies rates, trends, and patterns of occurrence;
(4) modifies the impact of prenatal exposures leading to adverse
physical and developmental impairments in infants, children, and adults
including integrating successful prevention programs into social and
medical environments, and evaluating innovative, effective, and
strategic health promotion programs; (5) develops, implements,
evaluates, and disseminates education and communication interventions
that lead to the prevention of birth defects and developmental
disabilities; (6) disseminates findings of epidemiologic studies to the
scientific and public health communities, and to the general public;
(7) conducts prevention effectiveness research to evaluate
interventions strategies for the prevention of birth defects and
developmental disabilities; (8) provides technical assistance to state
and local agencies on surveillance, epidemiologic research, prevention
program design and evaluation, and prevention effectiveness research;
(9) funds and coordinates grant and cooperative agreement programs and
other extramural activities to improve the knowledge base for the
prevention of birth defects and developmental disabilities through
surveillance, epidemiologic research, and applies research of
preventive interventions; (10) coordinates activities with other CDC
functional units, HHS, other federal agencies and appropriate private
organizations regarding research and prevention programs for birth
defects and developmental disabilities; (11) works with international
organizations in developing strategies for the prevention of birth
defects and developmental disabilities; and (12) disseminates finding
of research through direct contact with health authorities, publication
and distribution of special reports, publication in scientific and
technical journals,
[[Page 35678]]
conference presentations, and other appropriate means.
Division of Human Development and Disability (CUBC). The
Division of Human Development and Disability works to help children and
adults living with Autism, Attention Deficit Hyperactivity Disorder
(ADHD), Tourette Syndrome (TS) and other developmental disabilities
live to the fullest through better understanding developmental
disabilities from early detection into adulthood. The division improves
the health for children and adults with disabilities, in particular,
people with mobility limitations, intellectual disability and hearing
loss by informing disability health policy and practice, and
dissemination of disability health inclusion resources. This division:
(1) Designs and conducts surveillance of developmental disabilities to
identify rates, trends, and patterns of occurrence, and to evaluate the
effectiveness of prevention programs; (2) conducts epidemiologic
studies of developmental disabilities to identify causes and risk
factors for these conditions; (3) disseminates findings of
epidemiologic studies to the scientific and public health communities
and to the general public; (4) conducts applied research on public
health aspects of normal and abnormal child development (e.g., early
childhood, behavior problems in children); (5) conducts research on
interventions to prevent adverse child developmental outcomes; (6)
develops and disseminates information on public health aspects of
normal and abnormal child development; (9) conducts, analyzes, and
disseminates surveillance data to identify the distribution of
disabilities in state populations; health conditions that occur with
greater frequency among people with disabilities; and risk and
protective behaviors compared to people without disabilities; (10)
assists states and localities in developing their capacity for serving
individuals with developmental and other disabilities (e.g., developing
prevention strategies, providing training and technical consultation)
to prevent secondary conditions; (11) collaborates with universities,
federal, national, and state organizations to identify and address
knowledge and research gaps in developmental health and disability;
(12) collaborates with universities and other organizations to
investigate environmental, social, and technological supports to
promote inclusion; (13) develops programs that seek to identify health
risks, protective factors and measure the effectiveness of health
promotion activities for prevention of conditions related to
disability; and (14) oversees and manages grants, cooperative
agreements, contracts, and other funding instruments related to
division programs.
Child Development and Disability Branch (CUBCB). (1)
Promotes optimal child development and early identification of children
with developmental delays through assessing, developing, implementing,
disseminating and supporting evidence-based practices, tools, and
resources; (2) helps children and adults with autism, ADHD, TS and
other developmental disabilities live to the fullest by understanding
preventable risk factors, opportunities for early intervention, and the
effects of these disorders throughout the lifespan; (3) designs and
conducts surveillance of developmental disabilities to identify rates,
trends, and patterns of occurrence, and to evaluate the effectiveness
of prevention programs; (4) conducts epidemiologic studies of
developmental disabilities to identify causes and risk factors for
these conditions; (5) disseminates findings of epidemiologic studies to
the scientific and public health communities and to the general public;
(6) conducts prevention effectiveness research to evaluate
interventions strategies for the prevention of developmental
disabilities; (7) conducts epidemiologic studies to identify and
describe specific conditions and long-term outcomes of developmental
disabilities; (8) provides technical assistance to state and local
agencies on surveillance of developmental disabilities, epidemiologic
research, prevention program design and evaluation, and prevention
effectiveness research; (9) provides scientific leadership and
technical assistance in the development, application, improvement and
evaluation of public health activities, systems, and interventions
supporting optimal child development, including those with or at risk
for disabilities; (10) coordinates and collaborates on recommendations
for policy development at the federal and state levels and with the
private sector to promote social participation and optimal child
development, including those with or at risk for disabilities; (11)
conducts research to expand the knowledge base related to optimal early
development and health of children with or at risk of disabilities, and
investigates costs and effectiveness of intervention programs and
systems; (12) funds and coordinates grant and cooperative agreement
programs and other extramural activities to improve the knowledge base
for the prevention of developmental disabilities through surveillance,
epidemiologic research, and applies research of preventive
interventions; (13) coordinates activities with other CDC functional
units, HHS, other federal agencies and appropriate private
organizations regarding research and prevention programs for
developmental disabilities; (14) collaborates with international
organizations in developing strategies for the prevention of
developmental disabilities; (15) disseminates findings of research
through direct contact with health authorities, publication and
distribution of special reports, publication in scientific and
technical journals, conference presentations, and other appropriate
means; and (16) provides training in the epidemiology of developmental
disabilities to professionals throughout the United States and abroad.
Disability and Health Promotion Branch (CUBCC). (1)
Assists states and localities with the development, monitoring and
evaluation of early hearing detection and intervention (EHDI) tracking
and surveillance systems; (2) conducts research on etiology of hearing
loss and associated disabilities, cost and effectiveness and long-term
benefits of early identification and intervention (3) supports state-
based disability and health promotion programs, national, and state
organizations that promote and inform disability policy and practice,
including assessing, developing, implementing, and disseminating
disability inclusion models, tools, and resources; (4) collaborates
with and provides technical assistance, consultation, and training to
local, state, federal, and international agencies, universities and
governmental and non-governmental organizations on disability and
health related issues; (5) collaborates with local, state, federal, and
international agencies, and appropriate governmental and non-
governmental organizations to develop, review, and implement policies
that advance the health of people with disabilities across the
lifespan; (6) provides scientific leadership in the development,
application, extension, and improvement of health surveillance and
tracking systems related to disability and health; (7) conducts and
supports both qualitative and quantitative research to expand the
knowledge base related to disability and health across the lifespan;
(8) disseminates information from surveillance and health services
research, epidemiological research, health promotion and disease
[[Page 35679]]
prevention strategies, and policies related to disability and health;
(9) establishes collaborative partnerships with public and private
organizations of national and international stature to promote the
health of people with disabilities; (10) collaborates with funded non-
governmental agencies to disseminate best practices, identify areas of
need, facilitate development and distribution of educational materials,
and provide informational resources to states and affected populations
and their caregivers; and (11) provides leadership in health promotion
and disease prevention across the lifespan for individuals with
disabilities.
IV. Delegations of Authority: All delegations and redelegations of
authority made to officials and employees of affected organizational
components will continue in them or their successors pending further
redelegation, provided they are consistent with this reorganization.
(Authority: 44 U.S.C. 3101)
Alex M. Azar II,
Secretary.
[FR Doc. 2019-15691 Filed 7-23-19; 8:45 am]
BILLING CODE 4163-18-P